LDN: Immunomodulation and Neuroprotection for Complex Chronic Conditions - Evidence-Based Review

LDN, or Low Dose Naltrexone, is a unique off-label therapy showing promise for autoimmune, neuroinflammatory, and chronic pain conditions. This comprehensive monograph details its mechanism of action, clinical evidence, dosing protocols, and safety profile. Learn about the science behind LDN and its practical application in integrative and functional medicine. Product Description: Low Dose Naltrexone (LDN) Low Dose Naltrexone (LDN) refers to the off-label, compounded use of the generic drug naltrexone at doses approximately 1/10th to 1/50th of its standard dose.